Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen

NCT00332553 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00332553
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00332553 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Vasomotor Symptoms in Postmenopausal Women Receiving Combination Raloxifene and Oral Estrogen
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Completed
Start date
February 28, 2002
Completion date
May 31, 2004
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial safety, vasomotor symptoms